RxDoctor Payments Data

Amy Gibbens

Family · Harrisonville, MONPI 1679001754

Payments from drug & device makers

$6,318in general payments, 2019–2025

Across 373 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$713
  • Dexcom, Inc.$454
  • QOL Medical, LLC$366
  • Lilly USA, LLC$296
  • Merck$274
  • plus $3K from 54 others

What the payments were for

  • Food & beverage$6,318100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie81$1,110
Novo Nordisk42$713
Dexcom, Inc.29$454
QOL Medical, LLC14$366
Lilly USA, LLC18$296
Merck15$274
Otsuka America Pharmaceutical, Inc.11$214
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$199
Abbott9$175
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$173
Novartis8$141
Pfizer9$138
Boehringer Ingelheim7$127
Axsome Therapeutics, Inc.7$126
Biohaven Pharmaceutical Holding Company Ltd.6$96
Ardelyx, Inc.3$87
Radius Health, Inc.3$83
Kowa Pharmaceuticals America, Inc.6$82
Teva Pharmaceuticals USA, Inc.5$81
Collegium Pharmaceutical, Inc.5$81
Vanda Pharmaceuticals Inc.3$79
AstraZeneca(2 entities)4$73
Bayer4$72
Amgen4$65
Lundbeck LLC2$62
GSK4$59
Biohaven Pharmaceuticals, Inc.3$51
Sanofi-aventis U.S. LLC3$47
Daiichi Sankyo Inc.2$47
Corcept Therapeutics2$42
Phathom Pharmaceuticals, Inc.2$38
Shield Therapeutics Inc2$37
Amarin Pharma, Inc.2$35
Astellas Pharma US Inc2$32
Takeda Pharmaceuticals U.S.A., Inc.2$30
Esperion Therapeutics, Inc.2$30
Ferring Pharmaceuticals Inc.1$29
Mylan Specialty L.p.2$28
Bioventus LLC1$25
Boston Scientific1$24
Regeneron Healthcare Solutions, Inc.1$21
Johnson & Johnson1$21
Agile Therapeutics, Inc.1$20
Nevro Corp.1$19
Vertex1$19
Acella Pharmaceuticals, LLC1$18
Sunovion Pharmaceuticals Inc.1$18
Protega Pharmaceutials Inc1$17
Idorsia Pharmaceuticals US Inc1$17
Inspire Medical Systems, Inc.1$17
Antares Pharma, Inc.1$17
Azurity Pharmaceuticals, Inc.1$16
Corium, LLC1$16
GRT US Holding, Inc.1$16
Exact Sciences1$16
Sumitomo Pharma America, Inc.1$15
Tris Pharma Inc1$15
Eisai Inc.1$15
Virtus Pharmaceuticals LLC1$15
Sun Pharmaceutical Industries Inc.1$14

How this compares

$6,318 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$48,443
Medicare patients
123
Services billed
787

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide46$56,759
OzempicSemaglutide33$34,133
Tresiba Flextouch U-100Insulin Degludec13$8,617
ProgesteroneProgesterone, Micronized184$7,413
JardianceEmpagliflozin12$6,816
Liothyronine Sodium88$4,818
Estradiol131$2,788
Estradiol (Twice Weekly)Estradiol43$2,647
Np ThyroidThyroid,pork20$1,385
DottiEstradiol12$897
Duloxetine Hcl40$788
Aripiprazole27$653
Levothyroxine Sodium78$574
Bupropion XlBupropion Hcl23$456
Escitalopram Oxalate20$382

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$296$56,75946 claims
Novo NordiskOzempic$713$34,13333 claims
Boehringer IngelheimJardiance$127$6,81612 claims
Acella Pharmaceuticals, LLCNp Thyroid$18$1,38520 claims
Virtus Pharmaceuticals LLCLactulose$15$24814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.

Other family in Harrisonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →